Construction
Compare Stocks
4 / 10Stock Comparison
SWIM vs LEXX vs HAYW vs ATAI
Revenue, margins, valuation, and 5-year total return — side by side.
Biotechnology
Electrical Equipment & Parts
Medical - Pharmaceuticals
SWIM vs LEXX vs HAYW vs ATAI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Construction | Biotechnology | Electrical Equipment & Parts | Medical - Pharmaceuticals |
| Market Cap | $673M | $14M | $3.20B | $964M |
| Revenue (TTM) | $552M | $522K | $1.15B | $3M |
| Net Income (TTM) | $9M | $-11M | $161M | $-154M |
| Gross Margin | 28.5% | 84.9% | 45.0% | -259.1% |
| Operating Margin | 5.5% | -20.2% | 21.3% | -34.6% |
| Forward P/E | 34.4x | — | 17.2x | — |
| Total Debt | $35M | $109K | $13M | $25M |
| Cash & Equiv. | $71M | $2M | $330M | $18M |
SWIM vs LEXX vs HAYW vs ATAI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 21 | May 26 | Return |
|---|---|---|---|
| Latham Group, Inc. (SWIM) | 100 | 18.0 | -82.0% |
| Lexaria Bioscience … (LEXX) | 100 | 9.2 | -90.8% |
| Hayward Holdings, I… (HAYW) | 100 | 56.7 | -43.3% |
| Atai Beckley N.V (ATAI) | 100 | 21.7 | -78.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SWIM vs LEXX vs HAYW vs ATAI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SWIM is the clearest fit if your priority is income & stability.
- Dividend streak 2 yrs, beta 2.11
LEXX is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 52.0%, EPS growth -40.4%, 3Y rev CAGR 40.3%
- 52.0% revenue growth vs ATAI's -1.9%
- Beta 1.00 vs SWIM's 2.11, lower leverage
HAYW carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.
- -13.1% 10Y total return vs ATAI's -47.7%
- Lower volatility, beta 1.14, Low D/E 0.8%, current ratio 2.94x
- Beta 1.14, current ratio 2.94x
- Better valuation composite
ATAI is the clearest fit if your priority is momentum.
- +188.5% vs LEXX's -38.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 52.0% revenue growth vs ATAI's -1.9% | |
| Value | Better valuation composite | |
| Quality / Margins | 14.0% margin vs ATAI's -51.1% | |
| Stability / Safety | Beta 1.00 vs SWIM's 2.11, lower leverage | |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | +188.5% vs LEXX's -38.4% | |
| Efficiency (ROA) | 5.2% ROA vs LEXX's -178.4%, ROIC 10.2% vs -7.9% |
SWIM vs LEXX vs HAYW vs ATAI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
SWIM vs LEXX vs HAYW vs ATAI — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
HAYW leads in 2 of 6 categories
SWIM leads 2 • LEXX leads 0 • ATAI leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
HAYW leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HAYW is the larger business by revenue, generating $1.1B annually — 2200.2x LEXX's $522,000. HAYW is the more profitable business, keeping 14.0% of every revenue dollar as net income compared to ATAI's -51.1%. On growth, ATAI holds the edge at +17.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $552M | $522,000 | $1.1B | $3M |
| EBITDAEarnings before interest/tax | $69M | -$10M | $301M | -$103M |
| Net IncomeAfter-tax profit | $9M | -$11M | $161M | -$154M |
| Free Cash FlowCash after capex | $18M | -$9M | $80M | -$90M |
| Gross MarginGross profit ÷ Revenue | +28.5% | +84.9% | +45.0% | -2.6% |
| Operating MarginEBIT ÷ Revenue | +5.5% | -20.2% | +21.3% | -34.6% |
| Net MarginNet income ÷ Revenue | +1.5% | -20.7% | +14.0% | -51.1% |
| FCF MarginFCF ÷ Revenue | +3.3% | -16.7% | +7.0% | -29.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +5.3% | -100.0% | +11.5% | +17.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -40.0% | +53.4% | +70.3% | -75.0% |
Valuation Metrics
SWIM leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 21.7x trailing earnings, HAYW trades at a 65% valuation discount to SWIM's 62.0x P/E. On an enterprise value basis, SWIM's 7.6x EV/EBITDA is more attractive than HAYW's 9.8x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $673M | $14M | $3.2B | $964M |
| Enterprise ValueMkt cap + debt − cash | $636M | $13M | $2.9B | $971M |
| Trailing P/EPrice ÷ TTM EPS | 61.96x | -0.97x | 21.71x | -4.31x |
| Forward P/EPrice ÷ next-FY EPS est. | 34.41x | — | 17.19x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.16x | — |
| EV / EBITDAEnterprise value multiple | 7.64x | — | 9.81x | — |
| Price / SalesMarket cap ÷ Revenue | 1.23x | 20.17x | 2.85x | 3130.37x |
| Price / BookPrice ÷ Book value/share | 1.70x | 4.43x | 2.06x | 5.51x |
| Price / FCFMarket cap ÷ FCF | 25.82x | — | 14.19x | — |
Profitability & Efficiency
HAYW leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
HAYW delivers a 10.3% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $-2 for LEXX. HAYW carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to ATAI's 0.21x. On the Piotroski fundamental quality scale (0–9), SWIM scores 7/9 vs ATAI's 2/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +2.1% | -2.4% | +10.3% | -96.4% |
| ROA (TTM)Return on assets | +1.0% | -178.4% | +5.2% | -64.3% |
| ROICReturn on invested capital | +4.7% | -7.9% | +10.2% | -45.0% |
| ROCEReturn on capital employed | +4.3% | -2.2% | +8.6% | -50.4% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 3 | 7 | 2 |
| Debt / EquityFinancial leverage | 0.09x | 0.04x | 0.01x | 0.21x |
| Net DebtTotal debt minus cash | -$36M | -$2M | -$316M | $7M |
| Cash & Equiv.Liquid assets | $71M | $2M | $330M | $18M |
| Total DebtShort + long-term debt | $35M | $109,320 | $13M | $25M |
| Interest CoverageEBIT ÷ Interest expense | 1.66x | — | 4.07x | -68.93x |
Total Returns (Dividends Reinvested)
Evenly matched — SWIM and HAYW and ATAI each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HAYW five years ago would be worth $6,302 today (with dividends reinvested), compared to $1,023 for LEXX. Over the past 12 months, ATAI leads with a +188.5% total return vs LEXX's -38.4%. The 3-year compound annual growth rate (CAGR) favors SWIM at 31.0% vs LEXX's -14.4% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -9.2% | -2.0% | -6.4% | +3.6% |
| 1-Year ReturnPast 12 months | -3.7% | -38.4% | +7.3% | +188.5% |
| 3-Year ReturnCumulative with dividends | +124.6% | -37.2% | +27.3% | +99.5% |
| 5-Year ReturnCumulative with dividends | -80.1% | -89.8% | -37.0% | -79.8% |
| 10-Year ReturnCumulative with dividends | -78.9% | -85.7% | -13.1% | -47.7% |
| CAGR (3Y)Annualised 3-year return | +31.0% | -14.4% | +8.4% | +25.9% |
Risk & Volatility
Evenly matched — LEXX and HAYW each lead in 1 of 2 comparable metrics.
Risk & Volatility
LEXX is the less volatile stock with a 1.00 beta — it tends to amplify market swings less than SWIM's 2.11 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HAYW currently trades 83.3% from its 52-week high vs LEXX's 41.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.11x | 1.00x | 1.14x | 1.48x |
| 52-Week HighHighest price in past year | $8.97 | $1.55 | $17.73 | $6.75 |
| 52-Week LowLowest price in past year | $5.04 | $0.46 | $13.04 | $1.29 |
| % of 52W HighCurrent price vs 52-week peak | +64.1% | +41.3% | +83.3% | +59.4% |
| RSI (14)Momentum oscillator 0–100 | 47.0 | 36.1 | 51.5 | 51.5 |
| Avg Volume (50D)Average daily shares traded | 791K | 180K | 2.2M | 6.0M |
Analyst Outlook
SWIM leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: SWIM as "Buy", HAYW as "Hold", ATAI as "Buy". Consensus price targets imply 199.3% upside for ATAI (target: $12) vs 6.7% for HAYW (target: $16).
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | — | Hold | Buy |
| Price TargetConsensus 12-month target | $8.25 | — | $15.75 | $12.00 |
| # AnalystsCovering analysts | 8 | — | 10 | 4 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | 2 | — | 0 | — |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +0.2% | 0.0% |
HAYW leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SWIM leads in 2 (Valuation Metrics, Analyst Outlook). 2 tied.
SWIM vs LEXX vs HAYW vs ATAI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SWIM or LEXX or HAYW or ATAI a better buy right now?
For growth investors, Lexaria Bioscience Corp.
(LEXX) is the stronger pick with 52. 0% revenue growth year-over-year, versus -1. 9% for Atai Beckley N. V (ATAI). Hayward Holdings, Inc. (HAYW) offers the better valuation at 21. 7x trailing P/E (17. 2x forward), making it the more compelling value choice. Analysts rate Latham Group, Inc. (SWIM) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SWIM or LEXX or HAYW or ATAI?
On trailing P/E, Hayward Holdings, Inc.
(HAYW) is the cheapest at 21. 7x versus Latham Group, Inc. at 62. 0x. On forward P/E, Hayward Holdings, Inc. is actually cheaper at 17. 2x.
03Which is the better long-term investment — SWIM or LEXX or HAYW or ATAI?
Over the past 5 years, Hayward Holdings, Inc.
(HAYW) delivered a total return of -37. 0%, compared to -89. 8% for Lexaria Bioscience Corp. (LEXX). Over 10 years, the gap is even starker: HAYW returned -13. 1% versus LEXX's -85. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SWIM or LEXX or HAYW or ATAI?
By beta (market sensitivity over 5 years), Lexaria Bioscience Corp.
(LEXX) is the lower-risk stock at 1. 00β versus Latham Group, Inc. 's 2. 11β — meaning SWIM is approximately 112% more volatile than LEXX relative to the S&P 500. On balance sheet safety, Hayward Holdings, Inc. (HAYW) carries a lower debt/equity ratio of 1% versus 21% for Atai Beckley N. V — giving it more financial flexibility in a downturn.
05Which is growing faster — SWIM or LEXX or HAYW or ATAI?
By revenue growth (latest reported year), Lexaria Bioscience Corp.
(LEXX) is pulling ahead at 52. 0% versus -1. 9% for Atai Beckley N. V (ATAI). On earnings-per-share growth, the picture is similar: Latham Group, Inc. grew EPS 161. 9% year-over-year, compared to -272. 0% for Atai Beckley N. V. Over a 3-year CAGR, LEXX leads at 40. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SWIM or LEXX or HAYW or ATAI?
Hayward Holdings, Inc.
(HAYW) is the more profitable company, earning 13. 5% net margin versus -484. 6% for Atai Beckley N. V — meaning it keeps 13. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HAYW leads at 21. 1% versus -333. 4% for ATAI. At the gross margin level — before operating expenses — ATAI leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SWIM or LEXX or HAYW or ATAI more undervalued right now?
On forward earnings alone, Hayward Holdings, Inc.
(HAYW) trades at 17. 2x forward P/E versus 34. 4x for Latham Group, Inc. — 17. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ATAI: 199. 3% to $12. 00.
08Which pays a better dividend — SWIM or LEXX or HAYW or ATAI?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is SWIM or LEXX or HAYW or ATAI better for a retirement portfolio?
For long-horizon retirement investors, Lexaria Bioscience Corp.
(LEXX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 00)). Latham Group, Inc. (SWIM) carries a higher beta of 2. 11 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LEXX: -85. 7%, SWIM: -78. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SWIM and LEXX and HAYW and ATAI?
These companies operate in different sectors (SWIM (Industrials) and LEXX (Healthcare) and HAYW (Industrials) and ATAI (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: SWIM is a small-cap quality compounder stock; LEXX is a small-cap high-growth stock; HAYW is a small-cap quality compounder stock; ATAI is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.